1-4 of 4
Achilles Anagnostopoulos
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pevonedistat plus azacitidine vs azacitidine alone in higher-risk MDS/chronic myelomonocytic leukemia or low-blast-percentage AML

Clinical Trials & Observations
Lionel Adès, Larisa Girshova, Vadim A. Doronin, María Díez-Campelo, David Valcárcel, Suman Kambhampati, Nora-Athina Viniou, Dariusz Woszczyk, Raquel De Paz Arias, Argiris Symeonidis, Achilles Anagnostopoulos, Eduardo Ciliao Munhoz, Uwe Platzbecker, Valeria Santini, Robert J. Fram, Ying Yuan, Sharon Friedlander, Douglas V. Faller, Mikkael A. Sekeres
Journal: Blood Advances
Blood Adv (2022) 6 (17): 5132–5145.
https://doi.org/10.1182/bloodadvances.2022007334
Published: 2022
Includes: Supplemental data
Journal Articles

The TΑp63/BCL2 axis represents a novel mechanism of clinical aggressiveness in chronic lymphocytic leukemia

Stamatia Laidou, Dionysios Grigoriadis, Sofia Papanikolaou, Spyros Foutadakis, Stavroula Ntoufa, Maria Tsagiopoulou, Giannis Vatsellas, Achilles Anagnostopoulos, Anastasia Kouvatsi, Niki Stavroyianni, Fotis Psomopoulos, Antonios M. Makris, Marios Agelopoulos, Dimitris Thanos, Anastasia Chatzidimitriou, Nikos Papakonstantinou, Kostas Stamatopoulos
Journal: Blood Advances
Blood Adv (2022) 6 (8): 2646–2656.
https://doi.org/10.1182/bloodadvances.2021006348
Published: 2022
Includes: Supplemental data
Journal Articles

RPS15 mutations rewire RNA translation in chronic lymphocytic leukemia

Stavroula Ntoufa, Marina Gerousi, Stamatia Laidou, Fotis Psomopoulos, Georgios Tsiolas, Theodoros Moysiadis, Nikos Papakonstantinou, Larry Mansouri, Achilles Anagnostopoulos, Niki Stavrogianni, Sarka Pospisilova, Karla Plevova, Antonios M. Makris, Richard Rosenquist, Kostas Stamatopoulos
Journal: Blood Advances
Blood Adv (2021) 5 (13): 2788–2792.
https://doi.org/10.1182/bloodadvances.2020001717
Published: 2021
Includes: Supplemental data
Journal Articles

Inhibition of EZH2 and immune signaling exerts synergistic antitumor effects in chronic lymphocytic leukemia

Elisavet Chartomatsidou, Stavroula Ntoufa, Konstantia Kotta, Alessandra Rovida, Maria Anna Akritidou, Daniela Belloni, Elisabetta Ferrero, Theoni Trangas, Niki Stavroyianni, Achilles Anagnostopoulos, Richard Rosenquist, Paolo Ghia, Nikos Papakonstantinou, Kostas Stamatopoulos
Journal: Blood Advances
Blood Adv (2019) 3 (12): 1891–1896.
https://doi.org/10.1182/bloodadvances.2018030262
Published: 2019
Includes: Supplemental data